2. 供应商与价格

3. 结构

3.1 二维结构

3.2 三维结构

4. 国际命名与标识

4.1 IUPAC Name

[2,8-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-yl] 4-diethoxyphosphoryl-4-[ethoxy(methyl)phosphoryl]butanoate;[4-[[2,8-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-yl]oxy]-4-oxo-1-phosphonobutyl]phosphonic acid;[4-oxo-1-phosphono-4-[[2,5,7-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-yl]oxy]butyl]phosphonic acid;[2,5,7-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-yl] 4-diethoxyphosphoryl-4-[ethoxy(methyl)phosphoryl]butanoate

4.2 InChl

InChI=1S/C39H64O8P2.C38H62O8P2.C32H50O9P2.C31H48O9P2/c1-12-43-48(11,41)37(49(42,44-13-2)45-14-3)24-23-36(40)46-38-32(8)28-35-34(33(38)9)25-27-39(10,47-35)26-17-22-31(7)21-16-20-30(6)19-15-18-29(4)5;1-11-42-47(10,40)36(48(41,43-12-2)44-13-3)23-22-35(39)45-34-27-32(8)37-33(28-34)24-26-38(9,46-37)25-16-21-31(7)20-15-19-30(6)18-14-17-29(4)5;1-22(2)11-8-12-23(3)13-9-14-24(4)15-10-19-32(7)20-18-27-26(6)31(25(5)21-28(27)41-32)40-29(33)16-17-30(42(34,35)36)43(37,38)39;1-22(2)10-7-11-23(3)12-8-13-24(4)14-9-18-31(6)19-17-26-21-27(20-25(5)30(26)40-31)39-28(32)15-16-29(41(33,34)35)42(36,37)38/h18,20,22,28,37H,12-17,19,21,23-27H2,1-11H3;17,19,21,27-28,36H,11-16,18,20,22-26H2,1-10H3;11,13,15,21,30H,8-10,12,14,16-20H2,1-7H3,(H2,34,35,36)(H2,37,38,39);10,12,14,20-21,29H,7-9,11,13,15-19H2,1-6H3,(H2,33,34,35)(H2,36,37,38)

4.3 InChlKey

ZMPYVOBRCGDZCZ-UHFFFAOYSA-N

4.4 Canonical SMILES

CCOP(=O)(C)C(CCC(=O)OC1=CC2=C(C(=C1)C)OC(CC2)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)P(=O)(OCC)OCC.CCOP(=O)(C)C(CCC(=O)OC1=C(C2=C(C=C1C)OC(CC2)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C)P(=O)(OCC)OCC.CC1=CC(=CC2=C1OC(CC2)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)OC(=O)CCC(P(=O)(O)O)P(=O)(O)O.CC1=CC2=C(CCC(O2)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(=C1OC(=O)CCC(P(=O)(O)O)P(=O)(O)O)C

4.5 lsomeric SMILES

-

4.6 SDF文件

5. 波谱数据

5.1 ¹³C核磁共振谱(¹³C NMR)

5.2 ¹H核磁共振谱(¹H NMR)

5.3 质谱(MS)

5.4 红外光谱(IR)

5.5 紫外/可见光谱(UV/Vis)

6. 相关药材

7. 相关靶点

8. 相关疾病